SCHEMBL8936160

SCHEMBL8936160

O=c1cc(CBr)c2cc(Cl)c(Cl)cc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 5/20 0.43
GRIN3B O60391 5/20 0.43
GRIN1 Q05586 5/20 0.43
GRIN2A Q12879 5/20 0.43
GRIN2B Q13224 5/20 0.43
GRIN2C Q14957 5/20 0.43
GRIN3A Q8TCU5 5/20 0.43
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 3/20 0.41
CYP1A2 P05177 2/20 0.41
MAPT P10636 2/20 0.41
TSHR P16473 2/20 0.41
GRIA1 P42261 2/20 0.41
GRIA2 P42262 2/20 0.41
GRIA3 P42263 2/20 0.41
GRIA4 P48058 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30041447 0.79 LMNA (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL28402937 0.79 LMNA (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4112701 0.79 GPR84 (0.42) SMN1; SMN2CYP1A2KDM4ETP53AR
SCHEMBL8936045 0.77 GRIN2D (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL13326518 0.74 LMNA (0.47) SMN1; SMN2MEN1KMT2ALMNACYP1A2
SCHEMBL29792700 0.74 LMNA (0.47) SMN1; SMN2MEN1KMT2ALMNACYP1A2
SCHEMBL4045859 0.73 ALDH1A1 (0.59) SMN1; SMN2MEN1KMT2ACYP1A2TSHR
SCHEMBL29770446 0.73 ALDH1A1 (0.59) SMN1; SMN2MEN1KMT2ACYP1A2TSHR
SCHEMBL8936178 0.72 GPR17 (0.38) SMN1; SMN2MEN1KMT2ATSHRKDM4E
SCHEMBL8936157 0.72 CA12 (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5510338-A ADMINISTERING TO A MAMMAL TO RELIEVE PAIN AND TO TREAT CONVULSIONS, CEREBRAL ISCHEMIC DAMAGE, AND EMESIS GUILFORD PHARMACEUTICALS INC. (US) 1996-04-23 US disclosed
US-5342946-A Phosphonoalkylquinolin-2-ones as novel antagonists of non-NMDA ionotropic excitatory amino acid receptors GUILFORD PHARMACEUTICALS INC. (US) 1994-08-30 US disclosed